Purchase Order 75N93019P01198
Award Date
9/13/19
Potential Completion Date
9/17/20
Potential Value
$238K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10019, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $249,750.00 firm fixed-price definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines, differentiating stem cells, and expanding and validating neural progenitor cells from patients with conditions such as Alzheimer's...
This is a $15,375 firm-fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation, Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells,...
This is a $1,405,000.00 firm fixed price purchase order contract awarded by the National Human Genome Research Institute, a component of the Department of Health and Human Services, to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for services related to beta cell differentiation and cell assays, which aligns with the original solicitation that sought the development of assays to evaluate the differentiation of stem cells into insulin-producing beta cells. No...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $224,000.00 firm fixed price purchase order contract to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for the foundation to provide services including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells, and expanding,...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $150,000.00 firm fixed-price purchase order contract to the New York Stem Cell Foundation Inc., a non-profit organization that conducts stem cell research. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines, differentiating stem cells into insulin-producing beta cells, and expanding and validating neural...
This federal contract award from the National Human Genome Research Institute, an agency within the U.S. Department of Health and Human Services, was made to the New York Stem Cell Foundation Inc., a non-profit organization that conducts stem cell research. The contract, valued at $425,000.00, is for the generation of 50 induced pluripotent stem cell (iPSC) lines from fusion study fibroblast cell lines. No set-aside designation was used for this contract. The New York Stem Cell Foundation Inc....
This is a $1,399,499.93 firm fixed-price definitive contract awarded by the National Eye Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation Inc., a non-profit organization. The purpose of this contract is to obtain induced pluripotent stem cells (iPSCs) to advance the study of the functional basis of genetic variants associated with age-related macular degeneration (AMD). No set-aside designation was used for this award. The...
This is a $241,500 firm fixed price contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for the generation and characterization of human induced pluripotent stem cells (iPSCs), neural progenitor cells (NPCs), and stable transgenic iPSC lines from individuals with mood and anxiety disorders. This contract does not have a set-aside...
The Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute awarded a $499,999.98 firm fixed price purchase order to New York Stem Cell Foundation Inc. to provide beta cell differentiation and cell assay services for twelve cell lines. The place of performance is Bethesda, Maryland. No set-aside designation was indicated. As a non-profit organization, New York Stem Cell Foundation Inc. conducts stem cell research and directs private funds...
The Department of Health and Human Services' National Institutes of Health's National Human Genome Research Institute awarded a $986,250 firm fixed price purchase order to New York Stem Cell Foundation Inc. to provide beta cell differentiation and cell assay services. Under this two-year contract set to run from July 2020 through July 2022, New York Stem Cell Foundation will deliver products and services supporting the NIH's genomic research efforts, including differentiation of beta cells and...